从双模到单模:美国骨肉瘤发病率的转变

IF 3.4 2区 医学 Q2 Medicine
Emma Kar , Amrit Ammanamanchi , Miranda Yousif , Saroja Devi Geetha , Kendall Schwartz , Arya Suman Mishra , Jiali Ling , Kristie Nneoma Nonyelu , Bijun Sai Kannadath
{"title":"从双模到单模:美国骨肉瘤发病率的转变","authors":"Emma Kar ,&nbsp;Amrit Ammanamanchi ,&nbsp;Miranda Yousif ,&nbsp;Saroja Devi Geetha ,&nbsp;Kendall Schwartz ,&nbsp;Arya Suman Mishra ,&nbsp;Jiali Ling ,&nbsp;Kristie Nneoma Nonyelu ,&nbsp;Bijun Sai Kannadath","doi":"10.1016/j.jbo.2024.100613","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Osteosarcoma is the most common primary bone malignancy. It has classically been described as having a bimodal incidence by age. We sought to identify whether the bimodal incidence distribution still exists for osteosarcoma using the SEER and NIS databases.</p></div><div><h3>Methods</h3><p>Incidence rates of primary osteosarcoma between 2000–2021 were analyzed by age at diagnosis, year of occurrence, sex, and tumor site from the SEER Research Data, 17 Registries, Nov 2023 Sub (2000–2021). The incidence of cases in 35–64 year-olds and 65 and above was compared statistically to determine if there is an increased incidence in the later ages. Incidence of tumors of the long bones of the lower limbs from the NIS discharge database 2012–2019 was also analyzed for comparison.</p></div><div><h3>Results</h3><p>Overall, 5,129 cases of osteosarcoma were reported in the SEER database. Across the 22 calendar year span, a consistent first peak appeared in the second decade of life. There was no consistent second peak in the 35+ age group. There were 86,100 discharges with long bone tumors analyzed in the NIS data which exhibited nearly identical patterns.</p></div><div><h3>Conclusions</h3><p>Our analysis shows that the incidence of osteosarcoma is no longer bimodally distributed but rather unimodally distributed.</p></div>","PeriodicalId":48806,"journal":{"name":"Journal of Bone Oncology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212137424000939/pdfft?md5=52d2c1b2b6b14a31cc4ff7f26044de3a&pid=1-s2.0-S2212137424000939-main.pdf","citationCount":"0","resultStr":"{\"title\":\"From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States\",\"authors\":\"Emma Kar ,&nbsp;Amrit Ammanamanchi ,&nbsp;Miranda Yousif ,&nbsp;Saroja Devi Geetha ,&nbsp;Kendall Schwartz ,&nbsp;Arya Suman Mishra ,&nbsp;Jiali Ling ,&nbsp;Kristie Nneoma Nonyelu ,&nbsp;Bijun Sai Kannadath\",\"doi\":\"10.1016/j.jbo.2024.100613\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Osteosarcoma is the most common primary bone malignancy. It has classically been described as having a bimodal incidence by age. We sought to identify whether the bimodal incidence distribution still exists for osteosarcoma using the SEER and NIS databases.</p></div><div><h3>Methods</h3><p>Incidence rates of primary osteosarcoma between 2000–2021 were analyzed by age at diagnosis, year of occurrence, sex, and tumor site from the SEER Research Data, 17 Registries, Nov 2023 Sub (2000–2021). The incidence of cases in 35–64 year-olds and 65 and above was compared statistically to determine if there is an increased incidence in the later ages. Incidence of tumors of the long bones of the lower limbs from the NIS discharge database 2012–2019 was also analyzed for comparison.</p></div><div><h3>Results</h3><p>Overall, 5,129 cases of osteosarcoma were reported in the SEER database. Across the 22 calendar year span, a consistent first peak appeared in the second decade of life. There was no consistent second peak in the 35+ age group. There were 86,100 discharges with long bone tumors analyzed in the NIS data which exhibited nearly identical patterns.</p></div><div><h3>Conclusions</h3><p>Our analysis shows that the incidence of osteosarcoma is no longer bimodally distributed but rather unimodally distributed.</p></div>\",\"PeriodicalId\":48806,\"journal\":{\"name\":\"Journal of Bone Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2212137424000939/pdfft?md5=52d2c1b2b6b14a31cc4ff7f26044de3a&pid=1-s2.0-S2212137424000939-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bone Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212137424000939\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212137424000939","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景骨肉瘤是最常见的原发性骨恶性肿瘤。根据经典描述,骨肉瘤的发病率按年龄呈双峰分布。我们试图利用 SEER 和 NIS 数据库来确定骨肉瘤的双峰发病率分布是否仍然存在。方法我们根据 SEER 研究数据、17 个登记处、2023 年 11 月子数据库(2000-2021 年)中的诊断年龄、发病年份、性别和肿瘤部位对 2000-2021 年间原发性骨肉瘤的发病率进行了分析。对 35-64 岁和 65 岁及以上人群的发病率进行了统计比较,以确定年龄越大发病率是否越高。同时还分析了2012-2019年NIS出院数据库中下肢长骨肿瘤的发病率,以进行比较。结果SEER数据库共报告了5129例骨肉瘤病例。在 22 个日历年的时间跨度中,第一个高峰始终出现在生命的第二个十年。在 35 岁以上的年龄组中,没有出现一致的第二个高峰。我们的分析表明,骨肉瘤的发病率不再呈双峰分布,而是呈单峰分布。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States

Background

Osteosarcoma is the most common primary bone malignancy. It has classically been described as having a bimodal incidence by age. We sought to identify whether the bimodal incidence distribution still exists for osteosarcoma using the SEER and NIS databases.

Methods

Incidence rates of primary osteosarcoma between 2000–2021 were analyzed by age at diagnosis, year of occurrence, sex, and tumor site from the SEER Research Data, 17 Registries, Nov 2023 Sub (2000–2021). The incidence of cases in 35–64 year-olds and 65 and above was compared statistically to determine if there is an increased incidence in the later ages. Incidence of tumors of the long bones of the lower limbs from the NIS discharge database 2012–2019 was also analyzed for comparison.

Results

Overall, 5,129 cases of osteosarcoma were reported in the SEER database. Across the 22 calendar year span, a consistent first peak appeared in the second decade of life. There was no consistent second peak in the 35+ age group. There were 86,100 discharges with long bone tumors analyzed in the NIS data which exhibited nearly identical patterns.

Conclusions

Our analysis shows that the incidence of osteosarcoma is no longer bimodally distributed but rather unimodally distributed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.20
自引率
2.90%
发文量
50
审稿时长
34 days
期刊介绍: The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer. As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject. The areas covered by the journal include: Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment) Preclinical models of metastasis Bone microenvironment in cancer (stem cell, bone cell and cancer interactions) Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics) Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management) Bone imaging (clinical and animal, skeletal interventional radiology) Bone biomarkers (clinical and translational applications) Radiotherapy and radio-isotopes Skeletal complications Bone pain (mechanisms and management) Orthopaedic cancer surgery Primary bone tumours Clinical guidelines Multidisciplinary care Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信